The effect of AH 5158, pindolol, propranolol, D-propranolol on acute exercise tolerance in angina pectoris.
作者信息
Boakes A J, Prichard B N
出版信息
Br J Pharmacol. 1973 Mar;47(3):673P-674P.
Abstract
摘要
相似文献
1
The effect of AH 5158, pindolol, propranolol, D-propranolol on acute exercise tolerance in angina pectoris.AH 5158、吲哚洛尔、普萘洛尔、D-普萘洛尔对心绞痛患者急性运动耐量的影响。
Br J Pharmacol. 1973 Mar;47(3):673P-674P.
2
3
Beta-adrenergic receptor blocking drugs in angina pectoris.β-肾上腺素能受体阻滞剂在心绞痛中的应用。
Drugs. 1974;7(1):55-84. doi: 10.2165/00003495-197407010-00005.
4
5
[The pharmacodynamics of proxodolol when administered once and in a course of doses to patients with stenocardia of effort].[普索洛尔对劳力型心绞痛患者单次及疗程给药时的药效学]
Eksp Klin Farmakol. 1994 May-Jun;57(3):54-7.
6
7
The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris.普萘洛尔、吲哚洛尔和维拉帕米治疗劳力性心绞痛的临床及血流动力学效应。
Can Med Assoc J. 1984 Jun 1;130(11):1449-55.
8
[Qualification of patients with angina pectoris for beta-adrenolytic drug treatment].[心绞痛患者使用β-肾上腺素能阻滞剂治疗的资格]
Kardiol Pol. 1974;17(6):563-8.
9
Clinical investigation of an antagonist at alpha- and beta-adrenoceptors-AH5158A.α和β肾上腺素能受体拮抗剂AH5158A的临床研究
Br J Pharmacol. 1972 Feb;44(2):286-93. doi: 10.1111/j.1476-5381.1972.tb07265.x.
10
Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris.新型β-肾上腺素能阻滞剂ICI 66082对心绞痛患者运动血流动力学和气道阻力的影响。
Br Heart J. 1974 Dec;36(12):1194-1200. doi: 10.1136/hrt.36.12.1194.
引用本文的文献
1
Alpha- and beta-blockade in angina pectoris.心绞痛中的α和β受体阻滞剂
Drugs. 1984;28 Suppl 2:69-87. doi: 10.2165/00003495-198400282-00006.
2
Comparison of labetalol with other anti-hypertensive drugs.拉贝洛尔与其他抗高血压药物的比较。
Br J Clin Pharmacol. 1982 Jun;13(1 Suppl):41S-47S. doi: 10.1111/j.1365-2125.1982.tb01888.x.
3
Beta-adrenergic receptor blocking drugs in angina pectoris.β-肾上腺素能受体阻滞剂在心绞痛中的应用。
Drugs. 1974;7(1):55-84. doi: 10.2165/00003495-197407010-00005.
4
Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.拉贝洛尔，一种α和β肾上腺素能受体阻滞剂：其在治疗中的应用。研讨会综述。
Br J Clin Pharmacol. 1979;8(Suppl 2):239S-244S.
5
Uses of beta-adrenoceptor blocking drugs.β-肾上腺素能受体阻断药的用途。
J R Coll Physicians Lond. 1976 Oct;11(1):35-57.
6
The clinical pharmacology of beta adrenergic blocking drugs.β肾上腺素能阻断药物的临床药理学。
J R Coll Physicians Lond. 1976 Oct;11(1):21-34.
本文引用的文献
1
Preliminary investigations of a new beta-adrenoceptive receptor blocking drug, LB46, in man.新型β-肾上腺素能受体阻断药物LB46的人体初步研究。
Br J Pharmacol. 1969 Jun;36(2):368-72. doi: 10.1111/j.1476-5381.1969.tb09511.x.
2
Assessment of propranolol in angina pectoris. Clinical dose response curve and effect on electrocardiogram at rest and on exercise.心得安治疗心绞痛的评估。临床剂量反应曲线及对静息和运动时心电图的影响。
Br Heart J. 1971 Jul;33(4):473-80. doi: 10.1136/hrt.33.4.473.
3
Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.AH 5158的药理学；一种能阻断α和β肾上腺素能受体的药物。
Br J Pharmacol. 1972 Aug;45(4):660-75. doi: 10.1111/j.1476-5381.1972.tb08125.x.
4
Mechanism of action of beta-adrenergic receptor blocking agents in angina pectoris: comparison of action of propranolol with dexpropranolol and practolol.β-肾上腺素能受体阻滞剂治疗心绞痛的作用机制：普萘洛尔与右旋普萘洛尔及普拉洛尔作用的比较
Br Med J. 1969 Nov 15;4(5680):399-401. doi: 10.1136/bmj.4.5680.399.
Zotero 插件